FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy

SILVER SPRING, Md., June 22, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Elevidys, the first gene therapy for the treatment of pediatric patients 4 through 5 years of age with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who do…